Clinical Trial Update: Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating abemaciclib in combination with FOLFOX or FOLFIRI in patients with colorectal cancer that has metastasized to the liver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Abemaciclib (abemaciclib)
• FOLFIRI regimen (irinotecan + leucovorin + 5-fluorouracil)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Liver Metastases From Colorectal Cancer (mCRC) | Phase 2 | Status: ENROLLING_BY_INVITATION